Search results for "Adverse outcomes"

showing 10 items of 19 documents

Emergency Treatment of Anaphylactic Reactions in Air Rescue Missions: An Eight-Year Analysis of a German Rescue Helicopter Base.

2021

AbstractIntroduction:Anaphylactic reactions can lead to a life-threatening situation. In the event of anaphylaxis, rapid and targeted emergency treatment is indicated.Study Objective:The study sought to determine the emergency therapy administered for anaphylaxis in children and adults. Focus was placed on therapy with adrenaline. In addition, the study aimed to investigate demographic data, triggers, and hospitalization rates of the different severities of anaphylaxis.Methods:A retrospective analysis of anaphylactic reactions was conducted using data from prehospital emergency missions performed by the Air Rescue Dresden/Germany from 2008 through 2015 using the standardized application pro…

AdultMalemedicine.medical_specialtyAircraftEpinephrineAdverse outcomesmedicine.medical_treatmentEmergency NursingEmergency treatmentApplication protocolmedicineHumansInsect venomCardiopulmonary resuscitationChildAnaphylaxisEmergency TreatmentRetrospective Studiesbusiness.industryAnaphylactic reactionsmedicine.diseaseEpinephrineEmergency medicineEmergency MedicineFemalebusinessAnaphylaxismedicine.drugPrehospital and disaster medicine
researchProduct

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic …

2020

<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. <b><i>Methods:</i></b> We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydroneph…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Adverse outcomesUrologymedicine.medical_treatment030232 urology & nephrologyUrologyComorbiditySide effect03 medical and health sciencesYoung Adult0302 clinical medicineInformation campaignGermanyPandemicmedicineHumansHydronephrosisPandemicsStone diseaseRetrospective StudiesOutcomePyelonephritisbusiness.industrySARS-CoV-2IncidenceCOVID-19Middle Agedmedicine.diseaseNephrectomyHospitalizationCoronavirus030220 oncology & carcinogenesis2019-nCoVCollateral damageFemaleMorbiditybusinessEmergency Service HospitalResearch ArticleUrinary infectionUrologia internationalis
researchProduct

The Impact of Pre-Operative Malperfusion on Outcome in Acute Type A Aortic Dissection

2015

Abstract Background Malperfusion adversely affects outcomes in patients with acute type A aortic dissection, but reliable quantitative data are lacking. Objectives The aim of this study was to analyze the impact of various forms of malperfusion on early outcome. Methods A total of 2,137 consecutive patients enrolled in GERAADA (German Registry for Acute Aortic Dissection Type A) who underwent surgery between 2006 and 2010, of whom 717 (33.6%) had any kind of pre-operative malperfusion, were retrospectively analyzed. Results All-cause 30-day mortality was 16.9% and varied substantially according to the number of organ systems affected by malperfusion (none, 12.6%; 1 system, 21.3%; 2 systems,…

Aortic dissectionmedicine.medical_specialtySurgical strategyAdverse outcomesbusiness.industryIndependent predictormedicine.diseasePre operativeSurgeryAcute typeInternal medicinemedicineCardiologyIn patientbusinessCardiology and Cardiovascular MedicineOrgan systemJournal of the American College of Cardiology
researchProduct

Expanding education through user charges : what can be achieved in Malawi and other LDCs ?

1986

International audience; Two features mark the education sector in many LDCs today: first, education is publicly provided; and second. governments are faced with severe financial constraints. As a result, enrollmrnts are confined to low Ievels, and there is excess demand. To mitigate these adverse outcomes, we consider user charges as a means to mobilize additional resources for education. Under the circumstances that characterize most LDCs. we show that (i) families are willing to pay for education: (ii) the resources collected through user charges could finance a sizable expansion of education; and (iii) scholarships can offset the equity effects of user charges.

Economics and EconometricsDéveloppement de l'éducationMalawiOffset (computer science)Public economicsAdverse outcomes4. Education[SHS.EDU]Humanities and Social Sciences/Education05 social sciences[SHS.EDU] Humanities and Social Sciences/Education1. No povertyEquity (finance)050301 educationDeveloping countryEducation0502 economics and businessEconomicsÉducation050207 economicsFinancement privéPays en développement0503 education
researchProduct

Hypoproteinemia on the first day of life and adverse outcome in very preterm infants admitted to the neonatal intensive care unit

2012

International audience; OBJECTIVE: We aimed to investigate the relationship between day-1 hypoproteinemia and severe adverse outcome (SAO) in very preterm infants admitted to the neonatal intensive care unit (NICU). STUDY DESIGN: Retrospective study of all patients born from 24 to 31 weeks gestation and cared for in our NICU over an 8-year period. Infants were excluded if the serum protein value on the first day of life was not available. RESULT: A total of 913 patients were included. In all, 14.6% presented with SAO (death or severe neurological injury on cranial ultrasound). Hypoproteinemia (total protein level \textless40 g l(-1)) on day 1 of life occurred in 19.5 % of all patients. The …

MalePediatricsmedicine.medical_specialtyNeonatal intensive care unitAdverse outcomesLeukomalacia PeriventricularBirth weightDay of lifeMEDLINE[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/PediatricsDiseasesInfant Premature Diseases03 medical and health sciencesHypoproteinemia0302 clinical medicineIntensive Care Units Neonatal030225 pediatricsNeonatalMedicineBirth WeightHumans030212 general & internal medicinePrematureCerebral HemorrhageHypoproteinemia[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsPeriventricularbusiness.industryInfant NewbornObstetrics and GynecologyInfantBlood Proteinsmedicine.diseaseNewbornInfant newborn3. Good healthVery pretermIntensive Care UnitsPediatrics Perinatology and Child HealthFemalebusinessInfant PrematureLeukomalacia
researchProduct

Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors

2012

The H1N1 influenza pandemic strain has been associated with a poor prognosis in hospitalized patients. The present report evaluates the factors influencing prognosis.A total of 813 patients hospitalized with H1N1 influenza in 36 hospitals (nationwide) in Spain were analysed. Detailed histories of variables preceding hospital admission were obtained by interview, validating data on medications and vaccine with their attending physicians. Data on treatment and complications during hospital stay were recorded. As definition of poor outcome, the endpoints of death and admission to intensive care were combined; and as a further outcome, length of stay was used.The mean age was 38.5 years (SD 22.…

Malemedicine.disease_causeInfluenza A Virus H1N1 SubtypepreventionPregnancyInfluenza A virusPharmacology (medical)Young adultChildOriginal ResearchAged 80 and overNeuraminidase inhibitorbiologyMiddle AgedPrognosisHospitalizationInfectious DiseasesChild PreschoolFemaleMicrobiology (medical)Adultmedicine.medical_specialtyAdolescentCritical Caremedicine.drug_classNeuraminidaseadverse outcomesAntiviral AgentsYoung Adultlength of stayInternal medicineDiabetes mellitusIntensive careInfluenza HumanmedicineHumansSurvival analysisAgedPharmacologyPregnancyflubusiness.industrypandemicInfant NewbornInfantLength of Staymedicine.diseaseSurvival AnalysisSpainImmunologybiology.proteinbusinessNeuraminidase
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation

2019

Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have been associated with adverse outcomes after transcatheter aortic valve implantation (TAVI). Experimental data have suggested a potential molecular interaction. Therefore, we assessed the association of Gal-3 and CA125 with prognosis after TAVI.A total of 439 patients were enrolled. The primary endpoint was a composite of all-cause mortality or readmission for worsening heart failure after TAVI.The primary endpoint occurred in 16.4%. Gal-3 was dichotomized at ≥ 8.71 ng/mL into elevated and not elevated. Gal-3 was elevated in 31.9% and was associated with a higher risk of the primary endpoint (25% vs 12.4%, HR, 2.26; P.001). After m…

Malemedicine.medical_specialtyTranscatheter aorticAdverse outcomesGalectin 3030204 cardiovascular system & hematologyRisk AssessmentTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathGermanyInternal medicinemedicineClinical endpointHumansIn patientAgedRetrospective StudiesAged 80 and overbusiness.industryAortic Valve StenosisGeneral MedicinePrognosismedicine.diseaseSurvival RateGalectin-3CA-125 AntigenHeart failureAortic valve stenosisCardiologyFemalebusinessCarbohydrate antigenBiomarkersFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

2021

Abstract Individuals with the highest risk for adverse outcomes of COVID-19 should be prioritized by the vaccine allocation policies. We have conducted a literature review of published studies, which comprehend congenital heart disease (CHD) and COVID-19, in order to present the overall evidences of both exposure and clinical risk of patients with adult congenital heart disease (ACHD) and to propose a risk profile schema for those patients to be incorporated into vaccine distribution decisions.

Prioritizationmedicine.medical_specialtyHeart diseaseCoronavirus disease 2019 (COVID-19)business.industryAdverse outcomesCOVID-19medicine.diseaseRisk profileArticleRisk factorsSchema (psychology)RC666-701ACHDMedicineDiseases of the circulatory (Cardiovascular) systembusinessIntensive care medicineClinical risk factorVaccine
researchProduct

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

2018

To externally validate the prognostic impact of copeptin, either alone or integrated in risk stratification models, in pulmonary embolism (PE), we performed a post hoc analysis of 843 normotensive PE patients prospectively included in three European cohorts.Within the first 30 days, 21 patients (2.5%, 95% CI 1.5–3.8) had an adverse outcome and 12 (1.4%, 95% CI 0.7–2.5) died due to PE. Patients with copeptin ≥24 pmol·L−1 had a 6.3-fold increased risk for an adverse outcome (95% CI 2.6–15.5, p<0.001) and a 7.6-fold increased risk for PE-related death (95% CI 2.3–25.6, p=0.001). Risk classification according to the 2014 European Society of Cardiology (ESC) guideline algorithm identified 248…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyValidation studyAdverse outcomes030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineCopeptinRisk groupsRisk FactorsInternal medicinePost-hoc analysismedicineHumansProspective StudiesAgedAged 80 and overbusiness.industryGlycopeptidesMiddle Agedmedicine.diseasePrognosisPulmonary embolismIncreased riskLogistic Models030228 respiratory systemROC CurveRisk stratificationFemalebusinessPulmonary EmbolismAlgorithmsBiomarkersThe European respiratory journal
researchProduct